Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Autoimmune-related phenomena do not affect the progression or characteristics of lichen sclerosus in women.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Ruxolitinib helped a patient with alopecia areata regrow hair.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Different γδ T cell types have unique roles in causing alopecia areata.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Autoimmune gastritis is a common cause of iron deficiency and should be included in diagnostic guidelines.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

DM and AA may share a common cause.

Atopic dermatitis increases the risk of some autoimmune diseases.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Special cells can help regrow hair in alopecia areata.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Apremilast may help treat hair loss in alopecia areata.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

ILC1-like cells can independently cause alopecia areata.

CD44 variant changes start alopecia areata, but don't maintain it.

Clonally expanded CD8+ T cells cause alopecia areata.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.